Last 12 months
Inside the activity.
2 purchase rows · 26 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 2 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 07, 2023 Filed Mar 9, 2023 18:21 UTC |
PIMSTONE SIMON N.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 41,152 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001209191-23-017636 · doc4.xml · derivative · entry 7 PIMSTONE SIMON N. · CIK 0001620084 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 41,152 shares Expires 2023-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The exercise price was converted to U.S. dollars from $2.67 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. F5 · derivative.exercise_date: The shares subject to the options are fully vested and exercisable. F6 · derivative.expiration_date: Expiration date differs from originally reported date due to an automatic extension provided by the option plan as a result of the original expiration date falling during a Company blackout period. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 18:21 UTC |
PIMSTONE SIMON N.Director
|
SaleCommon Shares | 8,242 | $36.94 | $304,459.48 |
DisclosureSEC source: 0001209191-23-017636 · doc4.xml · nonDerivative · entry 6 PIMSTONE SIMON N. · CIK 0001620084 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,006 F4 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $36.89 to $37.03, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 18:21 UTC |
PIMSTONE SIMON N.Director
|
Tax withholdingCommon Shares | 1,618 | $37.13 | $60,076.34 |
DisclosureSEC source: 0001209191-23-017636 · doc4.xml · nonDerivative · entry 5 PIMSTONE SIMON N. · CIK 0001620084 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,248 F2 · price: Represents the closing price of the Company's common shares on March 6, 2023 for purposes of net settlement calculations. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 18:21 UTC |
PIMSTONE SIMON N.Director
|
Exercise / conversionCommon Shares | 30,864 | $2.59 | $79,937.76 |
DisclosureSEC source: 0001209191-23-017636 · doc4.xml · nonDerivative · entry 4 PIMSTONE SIMON N. · CIK 0001620084 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,866 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The exercise price was converted to U.S. dollars from $2.67 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 18:21 UTC |
PIMSTONE SIMON N.Director
|
SaleCommon Shares | 10,990 | $37.01 | $406,739.90 |
DisclosureSEC source: 0001209191-23-017636 · doc4.xml · nonDerivative · entry 3 PIMSTONE SIMON N. · CIK 0001620084 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,002 F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $36.93 to $37.13, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 18:21 UTC |
PIMSTONE SIMON N.Director
|
Tax withholdingCommon Shares | 2,160 | $37.13 | $80,200.80 |
DisclosureSEC source: 0001209191-23-017636 · doc4.xml · nonDerivative · entry 2 PIMSTONE SIMON N. · CIK 0001620084 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,992 F2 · price: Represents the closing price of the Company's common shares on March 6, 2023 for purposes of net settlement calculations. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 18:21 UTC |
PIMSTONE SIMON N.Director
|
Exercise / conversionCommon Shares | 41,152 | $2.68 | $110,287.36 |
DisclosureSEC source: 0001209191-23-017636 · doc4.xml · nonDerivative · entry 1 PIMSTONE SIMON N. · CIK 0001620084 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,152 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The exercise price was converted to U.S. dollars from $2.67 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. Read SEC document |
| December 12, 2022 Filed Dec 13, 2022 16:29 UTC |
AZAB MOHAMMADDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,086 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001209191-22-060939 · doc4.xml · derivative · entry 2 AZAB MOHAMMAD · CIK 0001309653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 3,086 shares Expires 2022-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The exercise price was converted to U.S. dollars from $2.67 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. F2 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| December 12, 2022 Filed Dec 13, 2022 16:29 UTC |
AZAB MOHAMMADDirector
|
Exercise / conversionCommon Shares | 3,086 | $2.68 | $8,270.48 |
DisclosureSEC source: 0001209191-22-060939 · doc4.xml · nonDerivative · entry 1 AZAB MOHAMMAD · CIK 0001309653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,905 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The exercise price was converted to U.S. dollars from $2.67 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. Read SEC document |
| November 25, 2022 Filed Nov 29, 2022 01:41 UTC |
PATOU GARYDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,057 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001209191-22-058916 · doc4.xml · derivative · entry 6 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 2,057 shares Expires 2022-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price was converted to U.S. dollars from $2.67 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. F6 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| November 25, 2022 Filed Nov 29, 2022 01:41 UTC |
PATOU GARYDirector
|
SaleCommon Shares | 1,937 | $34.79 | $67,390.36 |
DisclosureSEC source: 0001209191-22-058916 · doc4.xml · nonDerivative · entry 4 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,573 F4 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $34.76 to $34.90, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| November 25, 2022 Filed Nov 29, 2022 01:41 UTC |
PATOU GARYDirector
|
Tax withholdingCommon Shares | 120 | $34.37 | $4,124.40 |
DisclosureSEC source: 0001209191-22-058916 · doc4.xml · nonDerivative · entry 3 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,510 F3 · price: Represents the closing price of the Company's common shares on November 23, 2022 for purposes of net settlement calculations. Read SEC document |
| November 25, 2022 Filed Nov 29, 2022 01:41 UTC |
PATOU GARYDirector
|
Exercise / conversionCommon Shares | 2,057 | $2.68 | $5,512.76 |
DisclosureSEC source: 0001209191-22-058916 · doc4.xml · nonDerivative · entry 2 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,630 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: The exercise price was converted to U.S. dollars from $2.67 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. Read SEC document |
| November 23, 2022 Filed Nov 29, 2022 01:41 UTC |
PATOU GARYDirector
|
SaleCommon Shares | 2,057 | $34.33 | $70,609.61 |
DisclosureSEC source: 0001209191-22-058916 · doc4.xml · nonDerivative · entry 1 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,573 F1 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $34.24 to $34.36, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 17:04 UTC |
DiFabio AndreaChief Legal Officer
|
GrantStock Option (Right to Buy) · Derivative | 135,000 | $0.00 Strike: $34.77 | $0.00 |
DisclosureSEC source: 0001209191-22-056248 · doc4.xml · derivative · entry 1 DiFabio Andrea · CIK 0001692506 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,000 Underlying: Common Shares · 135,000 shares Expires 2032-11-06 F1 · derivative.exercise_date: Vesting 25% on the one year anniversary of the grant date, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 16:26 UTC |
AULIN SHERRYChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,511 | $0.00 Strike: $4.75 | $0.00 |
DisclosureSEC source: 0001209191-22-049015 · doc4.xml · derivative · entry 12 AULIN SHERRY · CIK 0001862144 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 6,511 shares Expires 2028-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 16:26 UTC |
AULIN SHERRYChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,292 | $0.00 Strike: $3.10 | $0.00 |
DisclosureSEC source: 0001209191-22-049015 · doc4.xml · derivative · entry 11 AULIN SHERRY · CIK 0001862144 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 2,292 shares Expires 2027-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 16:26 UTC |
AULIN SHERRYChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 813 | $0.00 Strike: $8.40 | $0.00 |
DisclosureSEC source: 0001209191-22-049015 · doc4.xml · derivative · entry 10 AULIN SHERRY · CIK 0001862144 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 813 shares Expires 2027-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 16:26 UTC |
AULIN SHERRYChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 32 | $0.00 Strike: $7.49 | $0.00 |
DisclosureSEC source: 0001209191-22-049015 · doc4.xml · derivative · entry 9 AULIN SHERRY · CIK 0001862144 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 32 shares Expires 2026-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 16:26 UTC |
AULIN SHERRYChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,000 | $0.00 Strike: $9.44 | $0.00 |
DisclosureSEC source: 0001209191-22-049015 · doc4.xml · derivative · entry 8 AULIN SHERRY · CIK 0001862144 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 9,000 shares Expires 2029-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 16:26 UTC |
AULIN SHERRYChief Financial Officer
|
SaleCommon Shares | 15,355 | $39.57 | $607,597.35 |
DisclosureSEC source: 0001209191-22-049015 · doc4.xml · nonDerivative · entry 7 AULIN SHERRY · CIK 0001862144 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $39.50 to $39.63, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 16:26 UTC |
AULIN SHERRYChief Financial Officer
|
Tax withholdingCommon Shares | 3,293 | $39.53 | $130,172.29 |
DisclosureSEC source: 0001209191-22-049015 · doc4.xml · nonDerivative · entry 6 AULIN SHERRY · CIK 0001862144 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,355 F1 · price: Represents the closing price of the Company's common shares on September 1, 2022 for purposes of net settlement calculations. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 16:26 UTC |
AULIN SHERRYChief Financial Officer
|
Exercise / conversionCommon Shares | 6,511 | $4.75 | $30,927.25 |
DisclosureSEC source: 0001209191-22-049015 · doc4.xml · nonDerivative · entry 5 AULIN SHERRY · CIK 0001862144 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,648 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 16:26 UTC |
AULIN SHERRYChief Financial Officer
|
Exercise / conversionCommon Shares | 2,292 | $3.10 | $7,105.20 |
DisclosureSEC source: 0001209191-22-049015 · doc4.xml · nonDerivative · entry 4 AULIN SHERRY · CIK 0001862144 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,137 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 16:26 UTC |
AULIN SHERRYChief Financial Officer
|
Exercise / conversionCommon Shares | 813 | $8.40 | $6,829.20 |
DisclosureSEC source: 0001209191-22-049015 · doc4.xml · nonDerivative · entry 3 AULIN SHERRY · CIK 0001862144 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,845 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 16:26 UTC |
AULIN SHERRYChief Financial Officer
|
Exercise / conversionCommon Shares | 32 | $7.49 | $239.68 |
DisclosureSEC source: 0001209191-22-049015 · doc4.xml · nonDerivative · entry 2 AULIN SHERRY · CIK 0001862144 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,032 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 16:26 UTC |
AULIN SHERRYChief Financial Officer
|
Exercise / conversionCommon Shares | 9,000 | $9.44 | $84,960.00 |
DisclosureSEC source: 0001209191-22-049015 · doc4.xml · nonDerivative · entry 1 AULIN SHERRY · CIK 0001862144 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 20:27 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $4.75 | $0.00 |
DisclosureSEC source: 0001209191-22-048508 · doc4.xml · derivative · entry 11 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 50,000 shares Expires 2028-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 20:27 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
SaleCommon Shares | 8,776 | $38.80 | $340,508.80 |
DisclosureSEC source: 0001209191-22-048508 · doc4.xml · nonDerivative · entry 8 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,796 F5 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $38.73 to $38.88, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 20:27 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
SaleCommon Shares | 35,103 | $38.03 | $1,334,967.09 |
DisclosureSEC source: 0001209191-22-048508 · doc4.xml · nonDerivative · entry 7 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,572 F4 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $37.44 to $38.35, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 20:27 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
Tax withholdingCommon Shares | 6,121 | $38.81 | $237,556.01 |
DisclosureSEC source: 0001209191-22-048508 · doc4.xml · nonDerivative · entry 6 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,675 F3 · price: Represents the closing price of the Company's common shares on August 31, 2022 for purposes of net settlement calculations. Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 20:27 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
Exercise / conversionCommon Shares | 50,000 | $4.75 | $237,500.00 |
DisclosureSEC source: 0001209191-22-048508 · doc4.xml · nonDerivative · entry 5 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,796 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2022 Filed Sep 2, 2022 20:27 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $4.75 | $0.00 |
DisclosureSEC source: 0001209191-22-048508 · doc4.xml · derivative · entry 10 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 5,000 shares Expires 2028-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| August 31, 2022 Filed Sep 2, 2022 20:27 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 17,488 | $0.00 Strike: $2.67 | $0.00 |
DisclosureSEC source: 0001209191-22-048508 · doc4.xml · derivative · entry 9 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 17,488 shares Expires 2022-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| August 31, 2022 Filed Sep 2, 2022 20:27 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
SaleCommon Shares | 21,352 | $38.57 | $823,546.64 |
DisclosureSEC source: 0001209191-22-048508 · doc4.xml · nonDerivative · entry 4 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,796 F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $38.18 to $38.83, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| August 31, 2022 Filed Sep 2, 2022 20:27 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
Tax withholdingCommon Shares | 1,572 | $37.86 | $59,515.92 |
DisclosureSEC source: 0001209191-22-048508 · doc4.xml · nonDerivative · entry 3 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,148 F1 · price: Represents the closing price of the Company's common shares on August 30, 2022 for purposes of net settlement calculations. Read SEC document |
| August 31, 2022 Filed Sep 2, 2022 20:27 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
Exercise / conversionCommon Shares | 5,000 | $4.75 | $23,750.00 |
DisclosureSEC source: 0001209191-22-048508 · doc4.xml · nonDerivative · entry 2 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,720 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2022 Filed Sep 2, 2022 20:27 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
Exercise / conversionCommon Shares | 17,488 | $2.67 | $46,692.96 |
DisclosureSEC source: 0001209191-22-048508 · doc4.xml · nonDerivative · entry 1 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,720 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2022 Filed Aug 16, 2022 17:31 UTC |
PIMSTONE SIMON N.Director
|
SaleCommon Shares | 20,000 | $38.87 | $777,400.00 |
DisclosureSEC source: 0001209191-22-046015 · doc4.xml · nonDerivative · entry 6 PIMSTONE SIMON N. · CIK 0001620084 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 F5 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $38.70 to $39.20, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| August 16, 2022 Filed Aug 16, 2022 17:31 UTC |
PIMSTONE SIMON N.Director
|
SaleCommon Shares | 32,058 | $38.29 | $1,227,500.82 |
DisclosureSEC source: 0001209191-22-046015 · doc4.xml · nonDerivative · entry 5 PIMSTONE SIMON N. · CIK 0001620084 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 F4 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $37.6431 to $38.6033, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 17:31 UTC |
PIMSTONE SIMON N.Director
|
SaleCommon Shares | 33,942 | $37.76 | $1,281,649.92 |
DisclosureSEC source: 0001209191-22-046015 · doc4.xml · nonDerivative · entry 4 PIMSTONE SIMON N. · CIK 0001620084 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,058 F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $37.5022 to $38.25, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| August 12, 2022 Filed Aug 16, 2022 17:31 UTC |
PIMSTONE SIMON N.Director
|
SaleCommon Shares | 1,000 | $39.15 | $39,150.00 |
DisclosureSEC source: 0001209191-22-046015 · doc4.xml · nonDerivative · entry 3 PIMSTONE SIMON N. · CIK 0001620084 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,000 Read SEC document |
| August 12, 2022 Filed Aug 16, 2022 17:31 UTC |
PIMSTONE SIMON N.Director
|
SaleCommon Shares | 47,000 | $38.60 | $1,814,200.00 |
DisclosureSEC source: 0001209191-22-046015 · doc4.xml · nonDerivative · entry 2 PIMSTONE SIMON N. · CIK 0001620084 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,000 F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $38.1397 to $39.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein Read SEC document |
| August 12, 2022 Filed Aug 16, 2022 17:31 UTC |
PIMSTONE SIMON N.Director
|
SaleCommon Shares | 43,135 | $37.91 | $1,635,247.85 |
DisclosureSEC source: 0001209191-22-046015 · doc4.xml · nonDerivative · entry 1 PIMSTONE SIMON N. · CIK 0001620084 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 F1 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $37.1353 to $38.1084, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| August 12, 2022 Filed Aug 16, 2022 21:36 UTC |
EMPFIELD JAMES R.EVP, Drug Discovery
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 45,000 | $0.00 Strike: $4.75 | $0.00 |
DisclosureSEC source: 0001209191-22-046017 · doc4.xml · derivative · entry 7 EMPFIELD JAMES R. · CIK 0001665430 · EVP, Drug Discovery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 45,000 shares Expires 2028-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| August 12, 2022 Filed Aug 16, 2022 21:36 UTC |
EMPFIELD JAMES R.EVP, Drug Discovery
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $3.10 | $0.00 |
DisclosureSEC source: 0001209191-22-046017 · doc4.xml · derivative · entry 6 EMPFIELD JAMES R. · CIK 0001665430 · EVP, Drug Discovery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 20,000 shares Expires 2027-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| August 12, 2022 Filed Aug 16, 2022 21:36 UTC |
EMPFIELD JAMES R.EVP, Drug Discovery
|
SaleCommon Shares | 21,875 | $38.68 | $846,125.00 |
DisclosureSEC source: 0001209191-22-046017 · doc4.xml · nonDerivative · entry 5 EMPFIELD JAMES R. · CIK 0001665430 · EVP, Drug Discovery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $38.6084 to $38.7884, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| August 12, 2022 Filed Aug 16, 2022 21:36 UTC |
EMPFIELD JAMES R.EVP, Drug Discovery
|
SaleCommon Shares | 35,868 | $38.08 | $1,365,853.44 |
DisclosureSEC source: 0001209191-22-046017 · doc4.xml · nonDerivative · entry 4 EMPFIELD JAMES R. · CIK 0001665430 · EVP, Drug Discovery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,875 F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $37.5101 to $38.5029, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| August 12, 2022 Filed Aug 16, 2022 21:36 UTC |
EMPFIELD JAMES R.EVP, Drug Discovery
|
Tax withholdingCommon Shares | 7,257 | $38.02 | $275,911.14 |
DisclosureSEC source: 0001209191-22-046017 · doc4.xml · nonDerivative · entry 3 EMPFIELD JAMES R. · CIK 0001665430 · EVP, Drug Discovery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,743 F1 · price: Represents the closing price of the Company's common shares on August 11, 2022 for purposes of net settlement calculations. Read SEC document |
| August 12, 2022 Filed Aug 16, 2022 21:36 UTC |
EMPFIELD JAMES R.EVP, Drug Discovery
|
Exercise / conversionCommon Shares | 45,000 | $4.75 | $213,750.00 |
DisclosureSEC source: 0001209191-22-046017 · doc4.xml · nonDerivative · entry 2 EMPFIELD JAMES R. · CIK 0001665430 · EVP, Drug Discovery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.